Systems and methods for monitoring biological samples electronically and optically.

By combining a multi-well plate, an illumination module, and an optical imaging module, the system enables real-time and continuous monitoring of cells, overcoming the limitations of existing technologies in evaluating cell biological functions and providing rich cell kinetic information and an efficient measurement method.

CN115397556BActive Publication Date: 2026-11-17AGILENT TECHNOLOGIES INC
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
CN202180025017.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2020-03-29
Filing Date
2021-03-26
Publication Date
2026-11-17
Estimated Expiration
2041-03-26

AI Technical Summary

Technical Problem

Existing cell matrix impedance monitoring technologies are limited to detecting changes in cells cultured on electrode surfaces, and cannot effectively expand the evaluation of cell biological functions.

Method used

A system was designed that combines a perforated plate, an illumination module, a bracket, and an optical imaging module to achieve continuous monitoring using electronic and optical methods. Images are captured through a transparent window of the perforated plate, and data analysis is performed using a computer processor to achieve the matching of impedance and optical data.

Benefits of technology

It enables real-time, continuous monitoring of cells, provides rich cell dynamics information, reduces measurement time, and improves the comprehensiveness and accuracy of monitoring.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115397556B_ABST
    Figure CN115397556B_ABST
Patent Text Reader

Abstract

The present invention provides a system for monitoring biological samples electronically and optically, the system comprising: a multi-well plate having a plurality of wells configured to receive a plurality of biological samples, each well having a set of electrodes and a transparent window without electrodes on the bottom surface of the well; an illumination module configured to illuminate the wells; a holder configured to receive the multi-well plate having an opening on its bottom that exposes the transparent window of the wells; and an optical imaging module capable of moving across different wells of the same multi-well plate to capture images through the window.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application claims the priority benefit of U.S. Patent Application No. 16 / 833,651, filed March 29, 2020, the entire contents of which are incorporated herein by reference. Technical Field

[0002] The present invention relates generally to systems and methods for monitoring biological samples electronically and optically, and more particularly to systems and methods for continuously monitoring the same biological sample electronically and optically in real time in a single well. Background Technology

[0003] Cell-based assays provide a preliminary evaluation of the role of therapeutic agents in human biology. Many cell-based assays are limited to endpoint measurements at a single time point, while a technique known as cellular matrix impedance monitoring allows for continuous monitoring of cells. Cellular matrix impedance monitoring assesses the interaction between cells and electrodes, where changes in cell attachment, growth, morphology, and motility on the electrodes lead to detectable changes. Therefore, cellular matrix impedance monitoring is a powerful tool for assessing cell proliferation and cell lysis.

[0004] While cellular matrix impedance monitoring (CMM) can reveal the kinetics of cellular response to potential therapeutic agents, it has its limitations. In particular, it is limited to detecting changes that occur when cells are cultured on electrode surfaces. Therefore, further advances are needed to expand the capabilities of CMM in evaluating the effects of therapeutic agents on cell biology. Summary of the Invention

[0005] In one aspect of the invention, a system for monitoring biological samples electronically and optically is provided, the system comprising: a multiwell plate having a plurality of wells configured to receive a plurality of biological samples, each well having a set of electrodes and a transparent window without electrodes on the bottom surface of the well; an illumination module configured to illuminate the wells; a holder configured to receive the multiwell plate having an opening at its bottom configured to expose the transparent window of the well; and an optical imaging module movable across different wells of the same multiwell plate to capture images through the window via the bottom of the opening. In some embodiments, the set of electrodes is configured to monitor cellular matrix impedance.

[0006] Although the lighting module may be a single lamp, preferably, the lighting module includes multiple lamps configured to independently illuminate one or more of the holes. More preferably, the lighting module includes an array of light-emitting diodes (LEDs). Most preferably, each LED is arranged to illuminate a single hole. In a preferred embodiment, the lighting module is a bright-field lighting module.

[0007] The bracket is configured to receive and preferably cover the perforated plate, and thus can provide a hinged cover. Preferably, the lighting module is engaged with the inner surface of the cover. The bracket may include a contact sensor for sensing reception of the plate. In some embodiments, the bracket electronically engages the perforated plate to communicate electronically with the plurality of electrode sets and engages the lighting module to transmit lighting commands.

[0008] Because the bottom of the opening of the bracket exposes the transparent window of the aperture, the optical imaging module can be positioned below the bracket and configured to move from the aperture to capture an image through the corresponding transparent window. In some embodiments, the optical imaging module is configured to capture one or more images from a single aperture at a time. In some embodiments, images are captured under bright-field illumination of the aperture, such as for determining cell counts or cell confluence parameters (e.g., percentage confluence). In other embodiments, images, such as fluorescence images, are captured after molecular excitation. The optical imaging system itself may include an excitation source configured to excite one or more molecules within or on the surface of a cell, such as fluorescent molecules conjugated to antibodies or antibody fragments to bind to biomolecules such as proteins, peptides, or nucleic acids. Examples of excitation sources may include one or more light sources selected from ultraviolet, violet, blue, green, yellow, orange, and red light.

[0009] In some embodiments, the optical imaging module includes a camera capable of continuously capturing a series of cell images at sufficiently short time intervals to visualize cell movement. In some embodiments, the camera captures at least 30 images per second. In other embodiments, the camera captures at least 60 images per second. In any one or both embodiments, the optical imaging module may include a camera, a bandpass filter, a tube lens, and an objective lens. High-speed imaging not only allows for the visual visualization of cell movement but also allows for the overlay of images from different light sources (e.g., bright-field illumination and multiple light sources of different wavelengths (each used to excite fluorescent molecules to produce a monochromatic fluorescence image)) to reveal cellular changes occurring during movement. In some embodiments, captured images from bright-field illumination and tricolor or more colors of fluorescence are overlaid to form a single image at each time point. Based on this imaging, cell counts or cell parameters, as well as the presence or absence of fluorescence, total fluorescence intensity, and average fluorescence intensity, can be determined, further revealing detailed cell dynamics.

[0010] The system may also include or be coupled to a computer processor communicatively coupled to: the bracket for selectively operating each of the plurality of electrode sets, optionally for electronically monitoring the cellular matrix impedance within one or more wells; the illumination module for selectively illuminating the one or more wells; and an optical imaging module for selectively moving thereand capturing and receiving images from the one or more wells. In some embodiments, the computer processor is programmed to capture images from the one or more wells via the optical imaging module in response to the one or more wells reaching or following a set impedance-based value or parameter from the electronic monitoring. In some embodiments, the computer processor is configured to electronically monitor cellular matrix impedance and optically monitor the same well, and is configured to pair impedance and optical data for display or analysis. In some embodiments, the computer processor is configured to electronically monitor cellular matrix impedance over a time period including a specific time interval between two consecutive electronic impedance measurements / monitorings; and to optically monitor the same well over a time period either during the electronic monitoring period or during a time period different from the electronic monitoring period. Exemplary impedance monitoring time periods can be programmed from as short as minutes to as long as hours, days, or even weeks. The impedance monitoring time interval between two consecutive impedance measurements can be specified or programmed from as short as seconds or less than one second to as long as one minute, several minutes, one hour, or even several hours. Optical monitoring time periods can be programmed within, outside of, or related to one or more impedance monitoring time periods.

[0011] While the system can be used with a single plate, it may also include two additional porous plates, each having multiple wells configured to receive multiple samples, each well having a set of electrodes and a transparent window without electrodes on the bottom surface of the well; two additional illumination modules configured to illuminate the wells of the two additional porous plates; and two additional holders configured to receive the two additional porous plates, each holder having an open bottom that exposes the transparent window of the well of the two additional porous plates; and wherein the optical imaging module is movable across all wells to capture images through all windows via the exposed bottom.

[0012] The system may also include cell or tissue culture containers not configured for electronic monitoring, wherein the optical imaging module is configured to capture images within the cell or tissue culture containers. As an exemplary embodiment, the system may include a multiwell plate having a plurality of wells configured to receive a plurality of biological samples, each well having a transparent bottom surface; an illumination module configured to illuminate the wells; a holder configured to receive the multiwell plate, the holder having an opening at its bottom configured to expose all of the transparent bottom surface of the wells; and an optical imaging module capable of moving across different wells of the same multiwell plate to capture images via the exposed bottom through the window.

[0013] In one related aspect of the invention, a method for monitoring cells is provided, the method comprising electronically monitoring cells within wells of a multiwell plate, each well having a set of cell matrix impedance monitoring electrodes and a transparent window without electrodes on the bottom surface of the well; and capturing an image through the transparent window from at least one well being electronically monitored. In some embodiments, the image is captured periodically at a fixed time interval between two consecutive image captures or irregularly within a time period during the electronic monitoring period, the method optionally including capturing the image between two consecutive image captures at a time interval equal to the time interval between two consecutive electronic measurements of the cell.

[0014] In some embodiments, prior to the step of capturing an image from the at least one aperture, the electronic monitoring outputs a result from the at least one aperture that satisfies a preset value, the result instructing the optical imaging module to capture the image from the at least one aperture. Examples of preset values ​​may include predetermined impedance-based values.

[0015] In some embodiments, the captured image is a bright-field image of the cells. In such embodiments, the method may further include counting cells based on the bright-field image, and optionally deriving the number of cells confluenced or a parameter (e.g., percentage confluence) from the bright-field image.

[0016] In other embodiments, the captured images include fluorescence images of the cells. In such embodiments, the method may include determining fluorescence parameters based on the images, the fluorescence parameters optionally being selected from one or more of total fluorescence count, total fluorescence intensity, and average fluorescence intensity. The fluorescence parameters are calculated or determined separately for each color of fluorescence image, such as blue, green, and red.

[0017] In other embodiments, the captured images include a bright-field image of the cells and a fluorescence image of the cells. In this embodiment, the method further includes deriving the number of cell confluences or parameters from the bright-field image, and optionally counting the cells from the bright-field image; determining fluorescence parameters from the fluorescence image, the fluorescence parameters optionally being selected from one or more of total fluorescence count, total fluorescence intensity, and average fluorescence intensity; and optionally, superimposing the bright-field image and one or more fluorescence images of different colors for one or more wells.

[0018] In one related aspect, a method for monitoring cells is provided, the method comprising electronically monitoring cells within wells of a multi-well plate over a time period, each well having a set of cell matrix impedance monitoring electrodes and a transparent window without electrodes on the bottom surface of the well; and capturing images through the transparent window during or outside the time period for electronic monitoring. The time period for electronic monitoring may be the same as or different from the time period for image capture. These time periods for electronic and optical monitoring can be specified or programmed to range from less than one minute to several hours, days, or even weeks. Within the time period for electronic monitoring, electronic monitoring can be continuous at specified fixed time intervals between two consecutive electronic measurements. Optical monitoring can be continuous at specified fixed time intervals between two consecutive image captures within the time period. These time intervals can be specified or programmed to range from a few seconds or less than one second to a minute, several minutes, an hour, or even several hours.

[0019] In some embodiments, the captured image is a bright-field image of the cells. In such embodiments, the method may further include counting cells based on the bright-field image, and optionally deriving the number of cells confluenced or a parameter (e.g., percentage confluence) from the bright-field image.

[0020] In other embodiments, the captured images include fluorescence images of the cells. In such embodiments, the method may include determining fluorescence parameters based on the images, the fluorescence parameters optionally being selected from one or more of total fluorescence count, total fluorescence intensity, and average fluorescence intensity. The fluorescence parameters are calculated or determined separately for each color of fluorescence image, such as blue, green, and red.

[0021] In other embodiments, the captured images include a bright-field image of the cells and a fluorescence image of the cells. In this embodiment, the method further includes deriving the number of cell confluences or parameters from the bright-field image, and optionally counting the cells from the bright-field image; determining fluorescence parameters from the fluorescence image, the fluorescence parameters optionally being selected from one or more of total fluorescence count, total fluorescence intensity, and average fluorescence intensity; and optionally, superimposing the bright-field image and one or more fluorescence images of different colors for one or more wells. Attached Figure Description

[0022] Figure 1A is a photograph of an exemplary system 10 for monitoring biological samples electronically and optically, in which an optional user interface 200 is displaying cell imaging data. Figure 1B depicts a main housing 12 with five usable trays 14.

[0023] Figure 2A shows the bracket 14 in its closed configuration. Figure 2B shows the bracket 14 in its open configuration. Figure 2C shows the double bracket 14 in both the open and closed positions.

[0024] Figure 3 shows the bright field lighting module 26 attached to the bracket cover 14.

[0025] Figure 4 depicts an exemplary perforated plate 20.

[0026] The photographs in Figure 5 show: a schematic diagram of a set of electrodes 42 suitable for use with a centrally positioned transparent window 44 (sub-Figure A); a photograph of the aperture 32 of the transparent window 44 with a set of electrodes 42 on the bottom surface and without electrodes 42 on the bottom surface of the porous plate 20 (refer to Figure 4) (sub-Figure B); and a cell image captured through the transparent window 44 (sub-Figure C).

[0027] Figure 6 shows an exemplary optical imaging module 26.

[0028] Figure 7 is a cross-section of an exemplary optical imaging module 26.

[0029] Figure 8 shows an exemplary optical imaging support 60 for the imaging module 26 of Figure 6, which allows two-dimensional linear motion (including motion along an axis parallel to linear track 66 and another axis parallel to linear track 70).

[0030] Figure 9A is an impedance-based plot showing the change over time in one time interval after treating MCF7 breast cancer cells transfected with lentivirus expressing red fluorescent protein with NK92 cells at different effector:target (E:T) ratios. Figure 9B shows the change over time in the red fluorescent cell count (indicating viable target cells) from the same assay. Figures 9C through 9E are images captured under bright-field illumination in the same wells with an E:T ratio of 2.5:1 before (left) NK92 cell addition, 12 hours after NK92 cell addition (middle), and 30 hours after NK92 cell addition.

[0031] Figure 10 illustrates exemplary captured and overlaid images, where the left subplot overlays three captured fluorescence images (red, green, and blue) with a captured bright-field illumination image, and the right subplot overlays three captured fluorescence images (red, green, and blue) without bright-field illumination. Cells exposed to fluorescent labels targeting annexin V (red), caspase 3 (green), and the cell nucleus (blue) are shown.

[0032] Figures 11A and 11B depict cytostromal impedance monitoring over a time period to demonstrate drug-induced apoptosis in real time. A549 blue cells were titrated with MG132 (Figure 11A) or astrococcus (Figure 11B). DMSO was used as a negative control. Error bars represent the standard deviation of samples from triplicate runs. Although impedance was measured continuously at 15-minute intervals to prevent overlap of error bars from adjacent time points, data points are shown only once per hour here.

[0033] Figures 12A to 12C provide plots of impedance monitoring over a time period, combined with live-cell imaging at different time points within that period. Impedance signals and the number of blue cell nuclei were tracked after treating A549 blue cells with DMSO (Figure 12A), 50 μm MG132 (Figure 12B), or 1 μm astrococcal (Figure 12C). Representative images are shown at pretreatment and 1 hour or 20 hours post-treatment. Error bars represent the standard deviation of samples from triplicate runs.

[0034] Figure 13 provides impedance-based plots before and after treatment with 5.5 μM MG1322. Images taken at 0, 20, and 40 hours post-treatment are also shown. The top images were each taken under bright-field illumination, and the bottom images were taken under fluorescence, showing annexin V staining (red), activated caspase 3 (green), and nuclear-localized BFP (blue fluorescent protein). Arrows indicate large vesicles containing phosphatidylserine in their outer leaflets.

[0035] Figures 14A through 14D provide an image-based, continuous tracking of MG132-induced apoptosis in A549 blue cells, using the number of blue cell nuclei (Figure 14A), % confluence (Figure 14B), the number of green (caspase 3 activated) cells (Figure 14C), and the number of red (annexin V bound) cells (Figure 14D). Error bars represent the standard deviation of samples from triplicate runs.

[0036] Figure 15 shows a comparison of the relative rates and relative abundance of different apoptosis phenomena in cells treated with 50 μM MG132. The error bars represent the standard deviation of samples from triplicate runs.

[0037] Figure 16 provides a table and graph illustrating the calculation of EC50 using dose-response curves. The area under the curve was calculated using real-time impedance data (e.g., expressed as a normalized cell index) (Figure 11A) and live-cell imaging data (number of green cells, number of red cells, and number of blue cell nuclei) (Figures 14A–14C), and plotted here as a function of MG132 concentration. The data were fitted to a four-parameter logistic equation to determine EC50. Detailed Implementation

[0038] The systems and methods described herein enable continuous and simultaneous monitoring of cell health and behavior from very different perspectives (i.e., from real-time electronic monitoring and live-cell imaging) in the same well. The streamlined workflow, high reproducibility, and quantitative kinetics of the systems make them ideal for a wide range of cell-based assays, including but not limited to cell health monitoring, proliferation, cytotoxicity, apoptosis, immune cell killing, cell receptor activation, and cell differentiation (including stem cell differentiation).

[0039] The continuous nature of the system and method offers two main advantages. First, compared to endpoint assays that only provide a snapshot of the process, real-time tracking ensures that no important phenomena are missed. Second, the continuous nature of the technique significantly reduces the amount of hands-on time required to run assays. Once the cells have been seeded and any treatments have been applied, no further intervention is necessary.

[0040] The system and method are preferably used to evaluate biological samples or their effects on cells. Cells can be primary cells isolated from any species or cells from a cell line. Cells can be genetically engineered cells. For example, these include cells from genetically modified organisms (such as from “gene knockout” organisms), cells that have been engineered to overexpress endogenous genes or transgenes, cells whose normal gene expression has been manipulated (e.g., by using antisense molecules or silent RNA), cells that have been modified by CRISPR and / or other gene-editing technologies, or cells that have been engineered to express therapeutic proteins (such as CHO cells).

[0041] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. All patents, applications, publications, and other publications referenced herein are incorporated herein by reference in their entirety. If any definition set forth in this section is contrary to or otherwise inconsistent with the definitions set forth in the patents, applications, publications, and other publications incorporated herein by reference, the definitions set forth in this section shall prevail.

[0042] As used in this article, “a or an” means “at least one” or “one or more”.

[0043] An "electrode" is a structure with high electrical conductivity (i.e., much higher conductivity than the surrounding material).

[0044] As used herein, "electrode structure" refers to a single electrode, particularly an electrode with a complex structure (e.g., a helical electrode structure), or a collection of at least two electrode elements electrically connected together. All electrode elements within an "electrode structure" are electrically connected.

[0045] As used in this article, “electrode element” refers to a single structural feature of an electrode structure, such as the finger-like protrusions of an interdigital electrode structure.

[0046] As used herein, an "electrode array" or "electrode structure unit" refers to two or more electrode structures constructed with dimensions and spacing such that they can operate as a single unit when connected to a signal source to generate an electric field in a spatial region surrounding the electrode structure. Preferred electrode structure units of the present invention can measure impedance changes caused by cell attachment to the electrode surface. Non-limiting examples of electrode structure units are interdigitated electrode structure units and concentric electrode structure units. Further examples of electrode structures may include a pair of small measuring / recording electrodes (e.g., circular microelectrodes with diameters ranging from less than 10 micrometers to hundreds of micrometers) and a much larger reference electrode. Multiple small recording electrodes forming a microelectrode array can share a common reference electrode. Such recording electrodes can be used for extracellular recording by amplifying and recording the voltage signal between the small recording electrode and the much larger reference electrode. In extracellular recording implementations, an extracellular recording system (including a voltage signal amplifier and other electronic hardware circuitry for measuring voltage, plus signal processing algorithms implemented in software and / or firmware) is used instead of an impedance measurement system (e.g., an impedance analyzer system, including electronic hardware circuitry for measuring current and voltage, and signal and data processing algorithms in software and / or firmware).

[0047] As used herein, an "electrode bus" is part of an electrode connection to a separate electrode element or substructure. The electrode bus provides a common conductive path from a separate electrode element or substructure to another electrical connection. In the device of this invention, the electrode bus can contact each electrode element of the electrode structure and provides an electrical connection path to an electrical trace leading to a connection pad.

[0048] As used herein, an "electrode trace," "conductive trace," or "electrical trace" is a conductive path extending from one end or boundary of an electrode, electrode element, or electrode structure toward a device or apparatus for connecting the electrode, electrode element, or electrode structure to an impedance analyzer. The end or boundary of the device may correspond to a connection pad on the device or apparatus.

[0049] As used herein, a "connection pad" is an area on a device or apparatus (e.g., a perforated plate) that is electrically connected to at least one electrode or all electrode elements within at least one electrode structure on the device or apparatus, and that is operatively connected to an external circuit (e.g., an impedance measurement circuit or signal source). The electrical connection between the connection pad and the impedance measurement circuit or signal source can be direct or indirect, via any suitable conductive means, such as leads or wires. Such conductive means can also pass through electrodes or conductive paths located on other areas of the device or apparatus.

[0050] As used herein, "interdigitated" means having protrusions from one direction and protrusions from different directions that interlace like the fingers of a hand (it should be noted that interdigitated electrode elements preferably do not contact each other).

[0051] As used herein, "electrodes (or electrode structures) having substantially the same surface area" means that the surface areas of the electrodes mentioned are substantially similar to each other, such that a change in impedance caused by cell attachment or growth on any one of the electrodes (or electrode structures) will contribute to an overall detectable change in impedance to the same or similar degree as a change in impedance caused by cell attachment or growth on any other electrode (or electrode structure). In other words, when the electrodes (or electrode structures) have substantially the same surface area, any one of the electrodes can contribute to an overall change in impedance after cell attachment or growth on that electrode. In most cases, the surface area ratio between the largest and smallest electrodes having "substantially the same surface area" is less than 10.

[0052] As used herein, "detectable impedance change between or among electrodes" (or "detectable impedance change between or among electrode structures") means a significant change in impedance between or among the electrodes (or electrode structures) that can be detected by an impedance analyzer or impedance measurement circuit when a molecular binding reaction occurs on the electrode surface. Impedance change refers to the difference in impedance value when cells are attached to the electrode surface and when cells are not attached to the electrode surface, or the difference in impedance value when the number, type, activity, adhesion, or morphology of cells attached to the electrode-containing surface of the device changes. In most cases, an impedance change greater than 0.1% is detectable. Preferably, a detectable impedance change is greater than 1%, 2%, 5%, or 8%. More preferably, a detectable impedance change is greater than 10%. The impedance between or among electrodes is typically a function of the frequency used to measure the applied electric field. "Detectable impedance change between or among electrodes" does not require that the impedance change be detectable at all frequencies. "Detectable impedance change between or among electrodes" only requires a detectable impedance change at any single frequency (or multiple frequencies). Furthermore, impedance has two components: resistance and reactance (reactance can be divided into two categories: capacitive reactance and inductive reactance). "Detectable impedance change between or in between electrodes" only requires that either resistance or reactance has a detectable change at any single frequency or multiple frequencies. In this disclosure, impedance is electrical or electronic impedance. Methods for measuring such impedance are achieved by: (1) applying a voltage between or in between electrodes at a given frequency (or multiple frequencies, or having a specific voltage waveform), and monitoring the current through the electrodes at said frequency (or multiple frequencies, or having a specific waveform), dividing the voltage amplitude by the current amplitude to derive the impedance value; (2) applying a current with a single frequency component (or multiple frequencies, or having a specific current waveform) through said electrodes, and monitoring the voltage generated between or in between the electrodes at said frequency (or multiple frequencies, or having a specific waveform), dividing the voltage amplitude by the current amplitude to derive the impedance value; (3) other methods that can measure or determine the impedance. It should be noted that in the above description of "dividing the voltage amplitude by the current amplitude to derive the impedance value," the "division" is performed on the current amplitude and voltage amplitude at the same frequency. This impedance measurement is an electronic or electrical process that does not involve the use of any reagents.

[0053] As used herein, "at least two electrodes have substantially different surface areas" means that the surface areas of any of the electrodes are dissimilar to each other, such that impedance changes due to cell attachment or growth on the larger electrode will not contribute to the overall detectable impedance to the same or similar degree as impedance changes due to cell attachment or growth on the smaller electrode. Preferably, any impedance change due to cell attachment or growth on the larger electrode (often referred to as the "counter electrode") is significantly smaller than the impedance change due to cell attachment or growth on the smaller electrode (often referred to as the "working electrode" or "measuring electrode"). Typically, the surface area ratio between the largest and smallest electrodes is greater than 10. Preferably, the surface area ratio between the largest and smallest electrodes is greater than 20, 30, 40, 50, or 100. Examples of "at least two electrodes having substantially different surface areas" include the "Electronic Cell Matrix Impedance Sensing (ECIS)" method developed by Giaver and Keese.

[0054] As used in this article, “arranged in a row and column configuration” means that, in terms of electrical connection, the position of an electrode, electrode array, or switching circuit is identified by both row position number and column position number.

[0055] A “cell index” or “CI” is a parameter that can be derived from a measured impedance value and can be used to reflect changes in the impedance value. There are many methods for deriving or calculating the cell index. CI has been previously explained in detail, such as in US 8,344,742; US 7,470,533; US 7,192,752; PCT / US03 / 22557 and other patents. Each of these is incorporated herein by reference in its entirety. The “normalized cell index” for a given time point is calculated by dividing the cell index at a given time point by the cell index at a reference time point. Therefore, the normalized cell index is 1 at the reference time point. The “normalized cell index” has been previously explained in detail, such as in US 8,344,742; US 7,470,533; US 7,192,752; PCT / US03 / 22557 and other patents. Each of these is incorporated herein by reference in its entirety. The "incremental cell index" at a given time point is calculated by subtracting the cell index at a standard time point from the cell index at that given time point. Therefore, the incremental cell index is the absolute change in the cell index from the initial time (standard time point) to the measurement time. The term "incremental cell index" has been previously explained in detail, such as in US 8,344,742; US 7,470,533; US 7,192,752; PCT / US03 / 22557 and other patents. Each of these is incorporated herein by reference in its entirety. The "cell change index" or "CCI" is a parameter derived from the cell index, and the "CCI" at a given time point is equal to the first derivative of the cell index with respect to time divided by the cell index at said time point. The term "CCI" has been previously explained in detail, such as in US 8,344,742; US 7,470,533; US 7,192,752; PCT / US03 / 22557 and other patents. Each of these is incorporated herein by reference in its entirety.

[0056] As used herein, a “dose-response curve” refers to the cell’s response to a dose concentration of a test compound. The cell’s response can be measured by many different parameters. For example, it is hypothesized that the test compound is cytotoxic and causes cell death. Then, after treating cells with the test compound, the cell response can be measured by the percentage of non-viable (or viable) cells. A dose-response curve is constructed by plotting this percentage of non-viable (or viable) cells as a function of the test compound’s dose concentration. In this application, the percentage of non-viable (or viable) cells can be represented by a measured impedance value, or by a cell index derived from an impedance measurement, or by a cell change index. For example, for a given cell type and under specific cell physiological conditions (e.g., a specific cell culture medium), the cell index can be shown to have a linear or positive correlation with the number of viable cells in the well from which the cell index is derived from an impedance measurement. Therefore, in this application, a “dose-response curve” can be constructed by plotting the cell index as a function of the test compound’s dose concentration. It should be noted that, in general, the cell index is related not only to the number of viable cells in the well but also to cell morphology and cell attachment. Therefore, plotting the relationship between cell index and dose concentration provides not only information about cell number but also information about their physiological state (e.g., cell morphology and cell adhesion). Furthermore, a significant advantage of the system and apparatus of this application is that "dose-response curves" at multiple time points can be obtained in a single experiment, as the system allows for continuous monitoring of cells and provides impedance measurements at numerous time points over a time range from minutes to days or weeks.

[0057] As used herein, “each well contains substantially the same number of cells” means that the minimum number of cells in the well is at least 50% of the maximum number of cells in the well. Preferably, the minimum number of cells in the well is at least 60%, 70%, 80%, 90%, 95%, or 99% of the maximum number of cells in the well. More preferably, each well contains the same number of cells.

[0058] As used herein, “each well contains the same type of cells” means that each well contains the same type of cells for the intended purpose; each well does not have to contain exactly the same type of cells. For example, if the intended purpose is for each well to contain mammalian cells, then each well may contain the same type of mammalian cells (e.g., human cells) or different mammalian cells (e.g., human cells and other non-human mammalian cells such as mouse, goat, or monkey cells).

[0059] "Known compound" means at least one compound whose activity is known. In this invention, the known compound is preferably a compound whose direct or indirect effects on cells are known. Preferably, the structure of the known compound is known, but this is not necessary. Preferably, the mechanism of action of the known compound on cells is known; for example, as a non-limiting example, the one or more effects of the known compound on cells can be effects on cell viability, cell adhesion, apoptosis, cell differentiation, cell proliferation, cell morphology, cell cycle, IgE-mediated cell activation or stimulation, receptor-ligand binding, cell number, cell mass, cell circulation, etc.

[0060] An "impedance value" is the electrode impedance measured in a pore with or without cells. Impedance is typically a function of frequency, meaning the impedance value depends on the frequency at which the measurement is performed. For the purposes of this application, an impedance value refers to the impedance measured at a single frequency or multiple frequencies. Furthermore, impedance has two components: a resistance component and a reactance component. The impedance value in this application refers to either the resistance component or the reactance component, or both. Therefore, when measuring or monitoring an "impedance value," we mean measuring or monitoring resistance or reactance, or both. In many embodiments of the methods of this application, the impedance value also refers to a parameter value derived from the original measured impedance data. For example, a cell index, or a normalized cell index, or an incremental cell index can be used to represent an impedance value.

[0061] As used herein, a “liquid (fluid) sample” means a sample that is naturally present as a liquid or fluid (e.g., a biological fluid). “Liquid sample” also refers to a sample that is naturally present in a non-liquid state (e.g., a solid or a gas) but has been prepared into a liquid, fluid, solution, or suspension containing a solid or gaseous sample material. For example, a liquid sample may include a liquid, fluid, solution, or suspension containing biological tissue.

[0062] As used herein, "sample" means any substance that may contain portions to be separated, manipulated, measured, quantified, detected, or analyzed using the apparatus, microplate, or method described in this application. Samples are preferably biological samples, such as biological fluids or biological tissues. Examples of biological fluids include suspensions of cells in culture media, such as cell culture media, urine, blood, plasma, serum, saliva, semen, feces, sputum, cerebrospinal fluid, tears, mucus, amniotic fluid, etc. Biological tissues are aggregates of cells (often of a specific species) along with their intercellular matrix, forming a structural material of a human, animal, plant, bacterial, fungal, or viral structure, including connective tissue, epithelial tissue, muscle tissue, and nervous tissue. Examples of biological tissues also include organs, tumors, lymph nodes, arteries, and individual cells. Biological samples may also include cell suspensions and solutions containing biomolecules (e.g., proteins, enzymes, nucleic acids, carbohydrates, and chemical molecules bound to biomolecules).

[0063] A "test compound" is any compound that, in any assay, is used to explore its activity or one or more direct or indirect effects on cells. Test compounds can be any compound, including but not limited to small molecules, macromolecules, molecular complexes, organic molecules, inorganic molecules, biomolecules such as, but not limited to, lipids, steroids, carbohydrates, fatty acids, amino acids, peptides, proteins, nucleic acids, or any combination thereof. Test compounds can be synthetic compounds, naturally occurring compounds, derivatives of naturally occurring compounds, etc. The structure of a test compound can be known or unknown.

[0064] As an introduction, starting with Figure 1A, an exemplary system 10 configured for continuous, real-time electronic or optical monitoring of samples is shown communicating with a computer processor 100 equipped with software and a user interface 200. By collecting and analyzing distinct and clear streams of information from a single assay, system 10 offers multiple advantages for studying cell viability. The richness of information from this reused assay lies not only in the number of parameters it reports but also in the clarity / uniqueness of the perspective it provides. The system 10 described herein enables simultaneous and simultaneous monitoring of cell health and behavior from very different real-time cell impedance and live-cell imaging perspectives within the same well.

[0065] Turning to Figure 1B, system 10 is preferably sized for placement in a commercially available cell culture incubator used to regulate cell temperature, CO2, and humidity conditions. That is, system 10 is sized to fit within a cell culture incubator, such that the incubator, rather than system 10, regulates cell culture conditions such as temperature, CO2, and humidity. Although the size design can vary according to user needs, system 10 shown in Figures 1A and 1B has a footprint of approximately 430 mm × 445 mm × 410 mm.

[0066] The top of the main housing 12 specifically manifests as a platform with five trays 14, three of which 14A are configured for electronic (e.g., cell matrix impedance) and optical monitoring of biological samples, and two trays 14B are used for optical monitoring of biological samples without electronic monitoring. While a total of five trays 14 are shown, those skilled in the art will recognize that increasing the footprint of the system 10 can allow for additional trays 14. Furthermore, those skilled in the art will recognize that fewer trays 14 than those shown in FIG. 1 are possible (e.g., four, three, two, or a single tray 14), including the same or fewer “electronic” trays 14A (e.g., three, two, or one tray 14A) configured for both electronic and optical monitoring of biological samples and / or the same or fewer “optical-only” trays 14B (e.g., two or one) configured for optical-only monitoring of biological samples.

[0067] As shown more clearly in Figures 2A to 2C, each bracket 14A configured for electronic monitoring preferably has a hinged cover 16, which can be locked closed using a movable engagement handle 18. Locking the cover 16 closed ensures a tight fit between the electronic board 20 (see Figure 4) and the spring pin 22 (see Figure 2B) for electrical engagement, which connects to an impedance analyzer or impedance measurement circuit for monitoring impedance within the system 10 and ultimately for communication with an external computer processor 100 (Figure 1A) for electronic monitoring. However, as shown in Figure 2C, each bracket 14B configured only for optical imaging does not require electronic engagement between the board and the bracket components, and therefore does not require a mechanism for locking the cover 16 closed. In both cases, the outer side of the hinged cover 16 may be marked with a marking 24 consistent with the intended format of the board or container added to the bracket 14.

[0068] Within the holder (preferably along the cover 16) is an illumination module 26 configured to illuminate the interior of the holder 14. As better illustrated in FIG3, in a preferred embodiment, the illumination module 26 comprises an array of light-emitting diodes (LEDs), which itself is formed from a plurality of discrete LEDs 28 receiving instructions from a computer processor 100 (FIG. 1A) via electrical contacts 30. In some embodiments, the LED arrays can be interchanged via screws, for example, for different well formats (e.g., 6-well, 12-well, 20-well, 48-well, 96-well, 384-well) or other culture containers. Preferably, each diode 28 is assigned to a single well 32 of a 96-well plate (refer to FIG. 4-5) and is thus configured to independently illuminate the corresponding well 32 for imaging. By providing the diode 28 directly above the well 32, the system 10 clearly illuminates the entire well 32 to ensure high-quality imaging. In a preferred embodiment, the illumination module 26 is configured for bright-field illumination, meaning that the illumination module 26 emits white light. Consistent with conventional optical microscopy, the difference in white light intensity of the biological sample provides sufficient contrast to identify cellular components such as cell membranes, nuclei, and other fine details based on camera magnification, and can therefore be used for cell counting and / or cell confluence analysis or to ensure that cells settle correctly at the bottom of well 32 prior to electronic monitoring. Imaging can be further enhanced by staining the biological sample with image-enhancing dyes that improve the contrast or identification of live cells under bright-field illumination (e.g., dead cells absorb trypan blue) to assess cytotoxicity, cell viability, and / or cell proliferation.

[0069] The control of illumination is performed by a computer processor 100. For this purpose, the computer processor 100 can selectively illuminate one or more diodes 28 in response to results from electronic monitoring of a biological sample. For example, cytokine impedance monitoring can be used to monitor biological cells to assess cell growth, and after a set value or parameter indicating the establishment of a cell monolayer or a cell population is reached, the computer processor 100 can instruct the illumination of one or more electronically monitored wells 32 using one or more LEDs 28 to capture cell images. Furthermore, during experimental treatments (such as the administration of a test compound to assess its cytotoxicity), the computer processor 100 can selectively instruct the illumination of one or more LEDs 28 at predefined time points or in response to changes in cytokine impedance monitoring for cell imaging to confirm a reduction in cell population. Further, the computer processor 100 can use one or more diodes 28 from an illumination module 26 to instruct bright-field illumination to capture images simultaneously with electronic monitoring (e.g., cytokine impedance monitoring).

[0070] Returning to Figures 2B and 2C, the white light from the biological sample ultimately exits the holder 14 through the bottom opening 34. "Opening" means that the bottom 34 is not completely opaque. As will be discussed in more detail in subsequent paragraphs, the bottom opening 34 exposes a transparent window (see Figure 5), thus providing a path for capturing images. In embodiments configured for electron monitoring of cells, a slotted protective shield 36 may span the bottom opening 34 to protect the spring needle 22, particularly during loading or unloading of the porous plate 22 into or from the holders 14, 14A.

[0071] For completeness, the development of a suitable holder 14 for electronic monitoring must overcome the inherent challenges of electronic measurements of cells using multiwell plates. For example, in routine electronic monitoring of biological samples, containers such as multiwell plates fitted with electrodes require their own plug-in stations with complex electrode selection circuitry for communicating with and switching measurements to different sets of electrodes in different wells of the plate. Many of these circuits for switching and selecting measurement electrodes must be moved to provide the desired openings, thereby providing imaging through the bottom 34 of the holder 14. For example, Figure 2B illustrates the use of spring-loaded pins 22 (120 shown communicating with the 96-well electronic plate 20) as a lining portion of the outer periphery of the holder 14. However, moving or rerouting this circuitry to form the desired openings affects the electrical characteristics of the system 10. In particular, extending the electrical leads to move the desired electrode switching circuitry away from the spring-loaded pins increases the system's resistance and can lead to interference from electronic noise from other electrical components, such as the circuitry in system 10 of Figure 8 used to drive the linear motion stages 66 and 70, which will ultimately affect the resolution and accuracy of the electronic monitoring. This is particularly important in preferred electrode configurations, where the resistance of all wires used for switching and selecting each set of electrodes across all wells must be equal or approximately equal. Another challenge for electromonitoring of cells is that the electrode switching circuitry adds localized heat to system 10, heat previously dissipated beneath the insertion station within each bracket. Therefore, moving or reconfiguring the electrode switching / selection circuitry and wiring from their conventional placement also affects the heat generation of system 10, posing further challenges in developing such a system. Thus, achieving a system suitable for both electromonitoring and optical imaging of samples within the same well requires special engineering development of system 10, allowing the electrode switching and selection circuitry to be repositioned within system 10 without causing excessive localized heat generation and without affecting the performance of electromonitoring.

[0072] Through numerous innovative engineering design steps, the electrode switching and selection circuitry is positioned near the spring pin 22. The location and orientation of the electrode switching chips are designed to maximize the distance between the chips, despite limited space available for minimizing localized heat generation. Furthermore, the printed circuit board (PCB) is designed with appropriate trace layouts on different layers of the conductive plane to minimize variations in electrode resistance between the spring pin 22 and the circuit switching chips for each set of electrodes across all holes on the via board. Additionally, the electrical signal wires / routes are designed with appropriate relationships relative to the electrical ground lines and ground planes on the PCB to minimize electrical interfaces from other circuits in the system.

[0073] Referring now to Figures 2B and 2C, each bracket 14 may include a force sensor 38 that, when pressed, signals the perforated plate 20 and the closed cover 16. Upon signaling, the bracket 14 is ready for electronic and / or optical monitoring.

[0074] Turning to Figures 4 and 5, preferably, each well 32 of the electron plate 20 has a set of electrodes 42 and a transparent window 44 on the bottom surface of the well 32 without electrodes 42. By providing an area with electrodes 42 and a transparent area without electrodes 42, at least two clearly distinct measurements can be performed in a single well 32. In particular, electronic monitoring (e.g., cell matrix impedance monitoring) can be performed using the set of electrodes 42, and optical imaging can be performed by focusing the optical imaging module 46 (Figure 6) through the bottom 34 of the bracket opening (see Figures 2B and 2C) and through the transparent window 44. As shown in Figure 4, the electron plate 20 is preferably a multi-well plate 20, which can be described as having “multiple wells” configured for electrical connection or electronic monitoring of the sample. Those skilled in the art will understand that, in addition to these “multiple wells,” one or more wells 32 may exist that do not have electrical connection or are not used for electronic monitoring. In this case, wells 32 lacking electronic monitoring capability can be used as control wells or as “optical imaging only” wells 32. Therefore, the electronic monitoring aperture 32 can be described as having a non-conductive substrate (e.g., the bottom of the aperture); an electrode array defined by a set of electrodes 42 fabricated on the substrate; and a transparent observation window 44 without electrodes 42 on the substrate.

[0075] The configuration of electrode 42 can be varied according to the user's needs or expectations, as long as the transparent window 44 for sample imaging can be preserved. In some embodiments, the electrode array is a microelectrode array (MEA) consistent with an electronic cellular matrix impedance sensing (ECIS) system as described by Gaiver and Keese, in which a single large reference electrode is paired with multiple small working or measuring electrodes. In ECIS, a small alternating current is applied across the electrode array. This results in a potential across the electrodes that is measured by the ECIS instrument. When cells are added to the ECIS array and attach to the measuring electrodes, they act as insulators, thereby increasing the impedance. As cells grow and cover the measuring electrodes, the current is impeded in a manner related to the number of cells covering the electrodes, cell morphology, and cell attachment properties. The impedance changes when cells proliferate or die.

[0076] Alternative and more preferred methods have been previously described (e.g., US 8,344,742; US 7,470,533; US 7,192,752; and other patents, each of which is incorporated herein by reference in its entirety), wherein each electrode array comprises two electrode structures 42A, 42B, and each electrode structure 42A, 42B comprises an electrode element 42C, but wherein the innermost electrode element 42C is removed to form a transparent window 44 (see schematic diagram shown in Figure 5, Part A). Electrode structures 42A, 42B are electrically coupled to connection pads or interfaces located on the edge of the substrate and thus configured to be electrically connected to spring pins 22 on the carrier 14. Each electrode array throughout the array has approximately uniform electrode resistance. In contrast to ECIS methods that monitor significant changes in cellular matrix impedance only at the working or measuring electrode (not at a large-area reference electrode), cell attachment or growth on any interdigitated electrode impedes current in a detectable manner related to the number of cells covering the electrode, cell morphology, and cell attachment properties. That is, in this configuration, all electrodes 42 act as measuring or working electrodes. Therefore, the electrode array can be two or more electrode structures 42A, 42B, constructed with dimensions and spacing such that they can operate as a single unit when connected to a signal source (e.g., via computer processor 100 and bracket 14) to generate an electric field in the spatial region surrounding the electrode structures 42A, 42B.

[0077] When the electronic monitoring is for cell matrix impedance monitoring, the electronic circuitry connects the set of electrodes 42 to the computer processor 100 via the bracket 14. Preferably, in this embodiment, the computer processor 100 communicates with impedance measurement circuitry or an impedance analyzer that can be fully integrated into the system 10. The impedance analyzer may include electronic hardware circuitry for measuring current and voltage, as well as signal and data processing algorithms in firmware and / or software. When connected to the impedance analyzer, the system 100 can measure differences in impedance values ​​related to cell behavior. For example, the system 10 can measure the difference in impedance values ​​when cells are attached to the electrode array and when cells are not attached to the electrode array, or it can detect differences in impedance values ​​when the number, type, activity, adhesion, or morphology of cells attached to the electrodes 42 changes. In particular, cell matrix impedance monitoring can reveal information about cell attachment or adhesion status on the matrix (including on electrode 42) (e.g., degree of cell diffusion, cell attachment area, cell attachment tightness, cell morphology), cell growth or proliferation status; the number of live and / or dead cells in the well; cytoskeleton changes and reorganization, and the number of cells undergoing apoptosis and / or necrosis.

[0078] In some implementations, the impedance analyzer is capable of measuring impedances between 0.1 ohms and 10 ohms in a frequency range of 1 Hz to 1 MHz. 5 The impedance is measured between 0.1 ohms and 10 ohms. More preferably, the impedance analyzer is capable of measuring impedances between 0.1 ohms and 10 ohms in the frequency range of 100 Hz to 100 kHz. 3 The impedance between ohms. The impedance analyzer is also preferably capable of measuring both the resistive and reactive components (capacitive and inductive reactance) of the impedance.

[0079] Additionally, system 10 includes electronic switches that can turn connections to each of the multiple sets of electrodes 42 on and off for selective monitoring. These switches are controlled by software programs preferably loaded into computer processor 100. The software program directs the connections of the electrode arrays to an impedance analyzer and monitors the cellular matrix impedance from the electrodes 42. During impedance monitoring, the impedance analyzer can monitor impedance at one or more frequencies. Most often, for a given measurement, impedance monitoring is performed at more than one time point. Therefore, the system can connect individual arrays to the impedance analyzer to monitor one, some, or all of the arrays at one or more time points. Furthermore, the switches allow for rapid, continuous monitoring of selected individual arrays at each desired monitoring time point. Each monitoring time point is, in effect, a narrow measurement time range (e.g., from one millisecond to several minutes) in the measurement in which impedance monitoring is performed. In some embodiments, the software is programmable to direct impedance monitoring of any well 32 of the plate 20 comprising the array at selected time intervals.

[0080] To facilitate the foregoing, system 10 can be used to efficiently and simultaneously perform multiple measurements using circuitry that digitally switches from monitoring the cellular matrix impedance of an array in one well 32 to monitoring the cellular matrix impedance of an array in another well 32 (whether from the same electronic plate 20 or from another electronic plate 20). In some embodiments, the software-controlled system is capable of performing impedance measurements on individual wells 32 at a single frequency in approximately one second or less. In other embodiments, cellular matrix impedance is monitored at millisecond resolution. Methods for monitoring cellular matrix impedance at millisecond resolution are found in US 10,533,985; US 10,012,636; US 9,709,548; and other patents. Each of the listed patents is incorporated herein by reference in its entirety. Thus, in some embodiments, two consecutive impedance measurements are monitored at an interval of 40 ms. In some embodiments, two consecutive impedance measurements are monitored at an interval of 20 ms. In some embodiments, two consecutive impedance measurements are monitored at an interval of 10 ms. In some implementations, two consecutive impedance measurements are monitored at an interval of less than 1 ms. In other implementations, two consecutive impedance measurements are monitored at an interval of less than 1 ms.

[0081] While the system is described primarily in relation to monitoring the cellular matrix impedance, those skilled in the art will recognize that it can also be adapted for extracellular recording. Extracellular recording can be performed by amplifying and recording the voltage signal between a small recording electrode and a much larger reference electrode (note that the use of such a small recording electrode and a large reference electrode is similar to that used in ECIS). In extracellular recording embodiments, an extracellular recording system (including a voltage signal amplifier and other electronic hardware circuitry for measuring voltage, plus signal processing algorithms implemented in software and / or firmware) is used instead of an impedance measurement system (e.g., an impedance analyzer system, including electronic hardware circuitry for measuring current and voltage, and signal and data processing algorithms in software and / or firmware).

[0082] Proceeding to Figures 6 and 7, the exemplary optical imaging module 26 is capable of capturing images from each aperture 32. In a preferred embodiment, the optical imaging module 26 is located within the main housing 12 (see Figure 1B) and below the bracket 14. The exemplary optical imaging module 26 includes a long working distance objective lens 48 at one end and a sealed CMOS camera 50 at the opposite end. In some embodiments, the camera captures 30 images per second. In some embodiments, the camera captures 40 images per second. In some embodiments, the camera captures 50 images per second. In some embodiments, the camera captures 60 images per second. In some embodiments, the camera captures 70 images per second. In some embodiments, the camera captures more than 70 images per second. This high-speed capture allows for the overlay of images taken under different conditions or filters. Tube lenses 52A and 52B and a bandpass filter 54 for enhanced imaging are also shown. The optical imaging system 26 receives instructions from a computer processor 100 and transmits images thereto. Therefore, even when the bracket 14 is closed (see Figures 2A to 2B), the bright field illumination of the aperture 32 allows the optical imaging system 26 to capture images through the bottom 34 of the opening in the bracket 14.

[0083] Preferably, the optical imaging system 26 further includes an excitation source 56, shown as a set of LEDs that guide light through a focusing lens 58 or guides the excitation of molecules within the aperture 32, such as to induce fluorescence for fluorescence imaging. While the LEDs correspond to yellow 56A, ultraviolet 56B, and blue 56C shown, excitation can include any number of lights between one and seven. For example, the excitation source 56 can include one or more lights, including ultraviolet, violet, blue, green, yellow, orange, and red light. Thus, the system 10 is configured to capture not only bright-field contrast images of cells but also fluorescently tagged markers, such as fluorescently tagged antibodies, antibody fragments, or other molecules that bind to cells. To this end, by adding a suitable fluorescent dye or fluorescently tagged molecule to the cell sample and capturing the fluorescence through the imaging module, the system can provide imaging of different stages such as cell proliferation, cell death, apoptosis, effector cell killing, cell-cell interactions, cell binding, DNA / RNA / protein upregulation, and DNA / RNA / protein downregulation.

[0084] As part of the optical imaging system 56, the excitation light source 56 is also controlled by a computer processor 100 loaded with software. Therefore, the computer processor 100 can instruct the on / off switching of each LED 56A, 56B, 56C and instruct high-speed image capture via the camera 50. In the operation of optically monitoring cells, one LED is turned on at a time, and the fluorescence image of the corresponding color is captured by the monochrome (black and white) CMOS camera 50. For example, the yellow LED 56A, ultraviolet LED 56B, and blue LED 56C will correspond to red, blue, and red fluorescence images, respectively. The captured monochrome image will be displayed with pseudo-color to represent the corresponding fluorescence color. Furthermore, the computer processor 100 can determine the number of live cells based on the imaging, as well as parameters such as the presence or absence of fluorescence (+ / -), the total fluorescence intensity of cells in each well or many wells, the average fluorescence intensity of cells in one or more wells, and other parameters. Additionally, the computer processor 100 can overlay fluorescence images (or monochrome or multicolor) and brightfield illumination images for comprehensive analysis.

[0085] Referring to Figures 5, 6, and 8, the optical module 56 is mounted to the movable support 60 for movement across the different windows 44. Typically, only movement along the X and Y axes is required, as lens adjustment or computer-controlled focusing can accommodate the minute focal length differences between the apertures 32. Therefore, the movable support 60 moves in both directions using an X-axis motor and timing belt 62, an X-axis cable holder 64, an X-axis linear motion guide 66, a Y-axis cable holder 68, and a Y-axis linear motion guide 70. A magnetic linear encoder 72 helps identify the X and Y coordinates of the optical imaging module 56.

[0086] As not mentioned above, the monitoring system 10 can also store and display data. Data can be displayed on screen 200, as printed data, or both. Preferably, the software allows input and display of experimental parameters, such as descriptive information including cell type, compound concentration, monitoring time interval, etc. Furthermore, data can be overlaid, such as showing a combination of optical imaging, bright-field illumination, and electronic monitoring data from different fluorescence channels (i.e., different fluorescence colors).

[0087] Preferably, the software can also analyze impedance data. In a preferred embodiment, the software can calculate the cell index (CI) at one or more time points for one or more wells. In some preferred embodiments, the software can calculate the cell change index (CCI) based on impedance measurements of one or more wells. The software can preferably generate graphs of impedance data and impedance values ​​(such as, but not limited to, CI or CCI) versus time. The software can also perform other analyses, such as calculating cell numbers based on CI, generating dose-response curves based on impedance data, calculating IC values ​​based on impedance values, and calculating kinetic parameters of cell growth or behavior based on impedance values ​​and impedance value curves. The software of the impedance monitoring system can also store and display analyses of the data, such as calculated impedance values ​​and kinetic parameters derived therefrom. The data can be displayed on a screen, as printed data, or both.

[0088] Similarly, the software can also be used to analyze the captured images. Preferably, the software can perform cell counting based on the images and can plot data changes over time for statistical analysis. Preferably, the software can also store and display analyses of the data, such as counts based on fluorescence imaging of different wavelength channels, counts based on bright-field illumination, and paired superimposed cell imaging results with corresponding electron monitoring time points.

[0089] For example, if the captured image is a bright-field image of cells, using the method may include determining the number or parameters of cell confluence or counting cells based on the bright-field image; or if the captured image is a fluorescence image of cells, using the method may include determining fluorescence parameters based on the image of each color, the fluorescence parameters optionally being selected from one or more of total fluorescence count, total fluorescence intensity, and average fluorescence intensity; or if the captured image includes both a bright-field image and a fluorescence image of cells, using the method may include deriving the number or parameters of cell confluence based on the bright-field image and optionally counting cells based on the bright-field image; determining fluorescence parameters based on the fluorescence image, the fluorescence parameters optionally being selected from one or more of total fluorescence count, total fluorescence intensity, and average fluorescence intensity; and optionally, superimposing the bright-field image and one or more fluorescence images of colors for one or more wells.

[0090] Observing Figures 11A through 12C (described in more detail in the examples below), the benefits of combining electronic monitoring of cells with live-cell imaging are particularly evident. Specifically, although cytostromal impedance can detect the rapid astrocytocin-mediated effects on A549 blue cells, impedance alone cannot explain the cellular phenomena causing this change. However, live-cell imaging revealed substantial cytoplasmic contraction, immediately demonstrating a mechanistic explanation for the large and rapid impedance response. Similarly, impedance has provided insights that cannot be obtained through imaging alone. In one such example, MG132 treatment detached cells from the electrodes but retained them in the wells (retained cell confluence >50%, (Figure 14B), where the confluence number was derived from bright-field images via an image analysis algorithm), while cell imaging showed the cells present within the wells, and impedance alone (impedance signal dropping to zero (Figure 11A)) revealed the strength of cytostromal attachment. In addition to the benefits of having two independent measurement techniques, it is important to note the objectivity of the impedance readout, which is reported directly without any processing or input from the user.

[0091] Returning together to Figures 1 through 8, a non-limiting use of the combined cellular matrix impedance monitoring and live-cell imaging of the same cell population is now described in more detail. Specifically, a method for monitoring cells is disclosed, comprising electronically monitoring cells within wells 32 of a multi-well plate 20, each well 32 having a set of electrodes 42 (preferably a set of cellular matrix impedance monitoring electrodes 42), and a transparent window 44 on the bottom surface of the well 32 without electrodes 42; and capturing an image through the window 44 from at least one well 32 that is being or has been electronically monitored. According to this monitoring, the method may include generating an impedance-based curve (e.g., a CI curve) based on the change of the monitored impedance over time; and displaying the impedance-based curve and the corresponding optical image. The image can be captured from bright-field illumination or from fluorescence excitation (e.g., excitation of a fluorescent molecular label attached to an antibody, antibody fragment, or other binding molecule). Thus, the data can provide quantitative kinetics, revealing detailed information about cell health, behavior, and cell-cell interactions.

[0092] Methods for performing cell proliferation assays are also disclosed. In these assays, an increase in monitored impedance indicates an increase in cell number, which can be confirmed by corresponding real-time imaging. A growth curve of cells grown in the wells 32 of the multi-well plate 20 can be plotted as a function of impedance measurement or impedance values ​​derived from impedance measurement versus time, and presented together with cell images captured from the same wells 32 (particularly from bright-field illumination and / or from fluorescence imaging of pathways or markers associated with cell proliferation).

[0093] Relatedly, a method for generating at least one cell growth curve is provided, the method comprising: culturing cells over time in a multi-well plate 20, wherein each well 32 includes a set of electrodes 42 and a transparent window 44 on the bottom surface of the well 32 without electrodes 42; monitoring cell matrix impedance and capturing an optical image from the same well 32 through the window 44; generating an impedance-based curve based on the monitored impedance; and displaying the impedance-based curve and the corresponding optical image.

[0094] Combining growth curves of one or more cell types with real-time cell imaging can be used to determine kinetic parameters. For example, the proliferation rates of different primary cancer cells, or primary cancer cells of the same type but different grades, can be compared. In another example, primary cells from individuals with different genotypes can be compared. In yet another example, the proliferation rates of primary or stem cell lines can be compared. In yet another example, growth curves or parameters of control cells and genetically modified cells from cell lines can be compared. In yet another example, growth curves or parameters of virus-infected cells and control cells can be compared. Furthermore, systematic imaging features can be used to confirm growth, such as by performing cell counting or cell confluence calculations via images captured under bright-field illumination, or by counting cells stained with fluorescent molecules or fluorescently tagged binding molecules and captured under fluorescence imaging.

[0095] System 10 can also be used to study the effects of one or more test compounds on cells. An exemplary embodiment includes culturing cells over time in a multi-well plate 20, wherein each well 32 includes a set of electrodes 42 and a transparent window 44 on the bottom surface of the well 32 without electrodes 42; monitoring cell matrix impedance and capturing optical images from the same well 32 through the window 44; adding a test compound to at least one well in the well 32; continuing to monitor cell matrix impedance and capturing optical images from the same well 32 through the window 44; generating an impedance-based curve based on the changes in the monitored impedance over time; and displaying the impedance-based curve and the optical images from the corresponding wells. The change in effect can be determined by comparing the results after the addition of the compound with the results before the addition of the compound and / or by providing a solvent control to another well 32 containing cells and comparing the impedance-based curves and / or images between the wells 32.

[0096] Methods for comparing the effects of compounds on two or more cell types are also disclosed. An exemplary method includes culturing cells over time in a multi-well plate 20, wherein each well 32 includes a set of electrodes 42 and a transparent window 44 on the bottom surface of the well 32 without electrodes 44, wherein at least one well in the well 32 receives one cell type, and at least another well 32 receives a different cell type; monitoring cell matrix impedance and capturing optical images from each well in the well 32 containing cells; adding the same test compound to the well 32 containing each of the cell types; continuing to monitor cell matrix impedance and capturing optical images from each well in the well 32 containing cells and the test compound through the window 44; generating an impedance-based curve based on the monitored impedance changes over time; and displaying the impedance-based curve and the corresponding optical image for each well in the well 32 for comparison. Wells 32 may also include solvent controls, as is known in the art.

[0097] Methods for comparing the effects of two or more different compounds on cells are also disclosed. An exemplary method includes culturing cells over time in a multi-well plate 20, wherein each well 32 includes a set of electrodes 42 and a transparent window 44 on the bottom surface of the well 32 without electrodes 42, wherein at least two wells of the well 32 receive cells; monitoring cell matrix impedance and capturing optical images from each well of the well 32 containing cells; adding different test compounds to different wells 32 containing cells; continuing to monitor cell matrix impedance and capturing optical images from each well of the well 32 containing cells and test compounds through the window 44; generating impedance-based curves based on changes in the monitored impedance over time; and displaying the impedance-based curves and corresponding optical images for each well of the well 32 for comparison. Wells 32 may also include solvent controls, as is known in the art.

[0098] Relatedly, methods for performing assays to test the effects of different concentrations of one or more test compounds on cells are also disclosed. This dose-response relationship can be used to derive time-dependent IC5, IC10, IC20, IC30, IC40, IC50, IC60, IC70, IC80, IC90, or IC95, all of which can be derived from dose-response curves. Typically, IC50 is of the greatest interest. Determining the range of time-dependent IC50 of a compound provides information about when the compound's effect on cells is greatest. Therefore, an exemplary method includes culturing cells over time in a multi-well plate 20, wherein each well 32 includes a set of electrodes 42 and a transparent window 44 on the bottom surface of the well 32 without electrodes 42, wherein at least two wells of the well 32 receive cells; monitoring cell matrix impedance and capturing optical images from each well of the well 32 containing cells; adding different concentrations of a test compound to different wells 32 containing cells; continuing to monitor cell matrix impedance and capturing optical images from each well of the well 32 containing cells and the test compound through the window 44; generating an impedance-based curve based on the monitored impedance changes over time; and displaying the impedance-based curve and the corresponding optical image for each well of the well 32 for comparison, such as comparing their dose-response curves or dose relationships or comparing IC50 values ​​derived from each dose-response curve in the dose-response curves. As is known in the art, wells 32 may also include solvent controls.

[0099] A method for performing a real-time cytotoxicity assay of a compound is also disclosed. An exemplary embodiment includes culturing cells over time in a multi-well plate 20, wherein each well 32 includes a set of electrodes 42 and a transparent window 44 on the bottom surface of the well 32 without electrodes 42; monitoring cell matrix impedance and capturing optical images from each well in the wells 32 containing cells; adding a cytotoxic compound or a compound suspected to be cytotoxic to one or more wells 32 containing cells; continuing to monitor cell matrix impedance and capturing optical images from each well in the wells 32 containing cells and the added compound through the window 44; generating an impedance-based curve based on the monitored impedance changes over time; and displaying the impedance-based curve and the corresponding optical image for each well in the wells 32 for comparison. Wells 32 may also include a solvent control, as is known in the art.

[0100] Methods for analyzing and comparing the time-dependent cytotoxic effects of a first compound and a second compound on cell types are also disclosed. Exemplary embodiments include culturing cells over time in a multi-well plate 20, wherein each well 32 includes a set of electrodes 42 and a transparent window 44 on the bottom surface of the well 32 without electrodes 42; monitoring cell matrix impedance and capturing optical images from each well in the wells 32 containing cells; adding a first cytotoxic compound or a first compound presumed to be cytotoxic to one or more wells 32 containing cells and adding a second cytotoxic compound or a second compound presumed to be cytotoxic to another one or more wells 32 containing cells; continuing to monitor cell matrix impedance and capturing optical images from each well in the wells 32 containing cells and the added compounds through the window 44; generating an impedance-based curve based on the change in monitored impedance over time; and displaying the impedance-based curves and corresponding optical images for the wells 32 associated with the first compound and the second compound for comparison. Wells 32 may also include solvent controls, as is known in the art. In some embodiments, a time-dependent cytotoxic response to the first compound is determined at multiple dose concentrations. In some embodiments, a time-dependent cytotoxic response is determined for the second compound at multiple dose concentrations. In some embodiments, a time-dependent cytotoxic response is determined for both the first and second compounds at multiple dose concentrations.

[0101] In some embodiments, the first compound is a compound whose mechanism of cytotoxicity is known, and the second compound is a compound whose mechanism of cytotoxicity is unknown. If the time-dependent cytotoxic response from the second compound is similar to that of the first compound, then the cytotoxic effect of the second compound may follow a similar mechanism to that of the first compound.

[0102] Various methods can be used to compare the cytotoxic responses of compounds. The cell index (or cell number index) can optionally be calculated using the obtained impedance values. In some embodiments, the time-dependent IC50 of the compounds can be derived, and their cytotoxic responses can be compared by comparing their time-dependent IC50 curves based on cell index values. If the IC50 curves follow similar time-dependent trends, the two compounds may follow similar mechanisms of cytotoxicity.

[0103] In some implementations, a direct comparison of the time-dependent cytotoxic responses of two compounds is performed, wherein the concentrations of the two compounds may be the same or different. A direct comparison between time-dependent cytotoxic responses can be made by analyzing the slope of the measured response change (which is equivalent to the first derivative of the response with respect to time) and comparing the time-dependent slopes of the two compounds. In another approach, higher-order derivatives of the time-dependent cytotoxic response with respect to time can be analyzed. Comparing these higher-order derivatives can provide additional information about the mechanism of compound-induced cytotoxicity.

[0104] In some embodiments, analyzing real-time cytotoxic responses may include deriving time-dependent IC50 values ​​for the compound across multiple cell types. In some embodiments, analyzing real-time cytotoxic responses may include deriving the slope of the time-dependent cytotoxic response at a given compound concentration. In some embodiments, analyzing real-time cytotoxic responses may include deriving the higher-order derivative of the time-dependent cytotoxic response with respect to time at a given compound concentration.

[0105] Methods for evaluating the effects of proposed anticancer therapeutics on cancer cells are also disclosed. Exemplary embodiments include culturing cancer cells over time in a multi-well plate 20, wherein each well 32 includes a set of electrodes 42 and a transparent window 44 without electrodes on the bottom surface of the well 32; adding one or more proposed therapeutics to the wells; monitoring cellular matrix impedance and capturing optical images from each well in the wells 32 containing cells; adding effector cells, preferably from the same subject from whom the cancer cells were obtained, to the wells 32; continuing to monitor cellular matrix impedance and capturing optical images from each well in the wells 32 through the window 44; generating an impedance-based curve based on the monitored impedance changes over time; and displaying the impedance-based curve and the corresponding optical images from the wells 32. In some embodiments, the method includes adding CAR-T cells as effector cells. Wells 32 may also include solvent controls, as is known in the art.

[0106] A method for evaluating the cell lysis of cancer cells by engineered effector cells is also disclosed. An exemplary embodiment includes culturing cancer cells over time in a multi-well plate 20, wherein each well 32 includes a set of electrodes 42 and a transparent window 44 on the bottom surface of the well 32 without electrodes 42; monitoring cell matrix impedance and capturing optical images from each well in the well 32 containing cells; adding effector cells (preferably from the same subject from whom the cancer cells were obtained) engineered to display a conjectured binding site to the well 32; continuing to monitor cell matrix impedance and capturing optical images from each well in the well 32 through the window 44; generating an impedance-based curve based on the monitored impedance changes over time; and displaying the impedance-based curve and the corresponding optical images from the well 32. Wells 32 may also include solvent controls, as is known in the art.

[0107] A method for assessing cell lysis of cancer cells using a bispecific adaptor is also disclosed. An exemplary embodiment includes culturing cancer cells over time in a multi-well plate 20, wherein each well 32 includes a set of electrodes 42 and a transparent window 44 without electrodes on the bottom surface of the well 32; monitoring cell matrix impedance and capturing optical images from each well in the wells 32 containing cells; adding effector cells, preferably from the same patient as the cancer cells, to the wells 32; adding a bispecific adaptor configured to bridge the effector cells to the cancer cells; continuing to monitor cell matrix impedance and capturing optical images from each well in the wells 32 through the window 44; generating an impedance-based curve based on the monitored impedance changes over time; and displaying the impedance-based curve and the corresponding optical images from the wells 32. Wells 32 may also include solvent controls, as is known in the art.

[0108] As will be shown in more detail in the following embodiments, the systems and methods described herein combine the simplicity, analytical sensitivity, and objectivity of real-time impedance monitoring with the highly specific readouts of live-cell imaging to continuously track cellular processes with unparalleled information richness. Example I Real-time monitoring of immune cell-mediated killing of cancer target cells

[0109] MCF7 breast cancer cells were transfected with a lentivirus expressing red fluorescent protein (eLenti Red, Cat#8711011), seeded on an E-Plate (ACEA BIOSCIENCES, San Diego, CA) for 25 hours, and then treated with NK92 cells at different effector:target (E:T) ratios.

[0110] Optical imaging and impedance monitoring were performed simultaneously. As shown in Figures 9A and 9B, effector additions resulted in cancer cell death in an E:T ratio-dependent manner, as demonstrated by impedance monitoring (Figure 9A) and optical imaging (Figure 9B). Fluorescent object counting (Figure 9B) indicated the number of viable target cells.

[0111] Figures 9C to 9E are images taken at an E:T ratio of 2.5:1 from before (Figure 9C) to 30 hours later (Figures 9D and 9E), demonstrating the changes in target cell death over time. Example II Reusing real-time impedance and live-cell imaging to track cell killing

[0112] Cell maintenance and assays were performed at 37°C / 5% CO2 in F-12K medium (ATCC; catalog 30-2004) containing 10% heat-inactivated FBS (Corning, catalog 35016CV). Impedance was measured every 15 minutes, and images were acquired hourly. Four fields of view were captured for each channel (bright field, red, green, and blue) in each well. Exposure times were as follows: red (300 ms), green (300 ms), and blue (80 ms). A549 blue cell lines stably expressing nuclear-localized blue fluorescent protein (BFP) were generated by multiplicative 1-transduced A549 cells (ATCC; catalog CCL-185) infected with Agilent eLenti Blue (p / n 8711012). From day 2 to day 11 post-infection, 1 μg / mL puromycin was added to the growth medium to select transducers. To visualize activated caspase 3 in real time, Agilent eCaspase 3 NucView 488 (p / n 8711005) was added to the growth medium at a concentration of 5 μm. To visualize translocated phosphatidylserine in real time, Agilent eAnnexin V Red (p / n 8711007) was added to the growth medium at a concentration of 0.25 μg / mL. Agilent E-Plate VIEW microplates (p / n 00300601030) were also used. MG132 (Tocris; catalog number 1748 / 5) and astrococcalin (Calbiochem; catalog number 569396) stock solutions were dissolved in DMSO.

[0113] A549 blue cells (as described above) were seeded into E-PATE VIEW at a density of 10,000 cells / well. As the cells proliferated on day 1, they occupied an expanded surface area on the biosensor array, resulting in a steady increase in impedance signal (Fig. 11A and Fig. 11B). Without treatment, the cells grew to confluence, saturating the biosensor array and yielding a smooth impedance signal. Addition of the proteasome inhibitor MG132 or the pan-kinase inhibitor astrocortin at the 25-hour timepoint induced a significant reduction in impedance signal in a time- and dose-dependent manner. The kinetics of the drug-induced responses and the overall shape of the impedance trajectory differed for each compound. This is consistent with a large body of literature spanning over 10 years, which has demonstrated that the mechanism of action for impedance responses is generally unique for each type. Although both MG132 and astrocortin induce apoptosis, they elicit distinct cellular behaviors during cell death, which became very clear when real-time impedance was multiplexed with live-cell imaging.

[0114] Although A549 blue cells had covered most of the bottom of the wells by the 26-hour time point, they continued to proliferate for another 50 hours without the drug, thus aggregating the cells at a higher density (Fig. 12A). Consistent with this, the impedance signal plateaued at approximately 30 hours, while the total number of blue cell nuclei continued to increase until approximately 80 hours (Fig. 12A). Blue cell nuclei were counted using an image processing algorithm to statistically represent the number of blue objects in the blue fluorescence image. Each blue cell nucleus corresponds to an A549 cell because it is transduced to express nuclear-localized blue fluorescent protein. Therefore, the number of blue cell nuclei in the well corresponds to the number of live A549 blue cells present in the well. When A549 blue cells were treated with the four highest concentrations of MG132 (1.9, 5.5, 16.7, and 50 μm), the total number of blue cell nuclei decreased over time in a manner closely correlated with the decrease in impedance (Fig. 12B; data for the 50 μm treatment are shown only). Conversely, treatment with the four highest concentrations of asteroidin (0.125, 0.250, 0.500, and 1 μm) resulted in a sharp drop in impedance within the first few minutes, but had a mild effect on the number of blue cell nuclei over the subsequent 60 hours (Fig. 12C; data only for the 1 μm treatment are shown). Consistent with its ability to expel water from cells, one hour after the addition of asteroidin, A549 blue cells had shrunk so much that their cytoplasm was barely visible, leaving only the blue cell nuclei. Although these nuclei shrank in size and began to cluster together over time, they remained largely intact, explaining why the number of blue cell nuclei remained fairly constant in Fig. 12C. The combination of impedance and imaging described above clearly provides a more complete and nuanced understanding of drug-mediated killing of A549 cells than the understanding might have been provided by using either technique alone. Beyond simple cell counting, we then investigated the dynamics of the biochemical phenomena specific to the apoptotic killing pathway. Example III Simultaneously tracking MG132-mediated apoptosis from five different perspectives

[0115] Along with impedance and blue nucleus counts, MG132-induced apoptosis was also tracked by cell percentage confluence, caspase 3 activation (causing green fluorescence), and phosphatidylserine translocation (causing red fluorescence). As shown in Figure 13, the drug-induced decrease in impedance was closely correlated with the time accumulation of these apoptosis-specific markers. The bold white arrows in the subplots for 20-hour and 40-hour time points highlight large vesicles containing phosphatidylserine in their outer leaflets.

[0116] Next, the sequential response of A549 blue cells to MG132 was plotted using each image-based readout. The blue cell nucleus count (Fig. 14A) showed dependence on drug concentration, closely mirroring the impedance response seen in Fig. 11A. Despite a broad apoptotic response, the percentage confluence of cells never decreased below 50% throughout the assay (Fig. 14B), where the number of confluenced cells was derived from bright-field images using an image processing algorithm. This is consistent with the fact that, unlike in vivo where apoptotic cells and their debris are removed via phagocytosis, in vitro, a majority of apoptotic cells continue to occupy the bottom of the well (Fig. 12B). The fact that high concentrations of MG132 caused the impedance signal to drop to zero (Fig. 11A) while the percentage confluence never decreased below 50% indicates that the remaining cells were no longer attached to the bottom of the plate. The number of caspase 3-positive (fluorescent green) objects (Fig. 14C) and annexin V-positive (fluorescent red) objects (Fig. 14D) increased over time and showed a clear dependence on MG132 concentration. Considering the number of cells inoculated, their growth rate, and the percentage of cells displaying apoptosis markers (Fig. 13), the output numbers in Figs. 14A through 14C were consistent with expectations. To compare the relative rates and relative abundance of different apoptotic phenomena, the impedance response was plotted together with three different image-based readouts (Fig. 15). As expected, the time when the number of blue cell nuclei began to decrease (approximately 10 hours after MG132 addition) coincided with the time when caspase 3 activation and phosphatidylserine translocation became detectable. For the first 20 hours of drug treatment, the number of cells displaying caspase 3 and phosphatidylserine signaling was similar, but in the subsequent 40 hours, the number of cells with caspase 3 activation exceeded the number of cells with phosphatidylserine translocation by approximately 20%. Example IV Quantifying drug efficacy through simultaneous monitoring of cellular matrix impedance and optical imaging.

[0117] The EC50 of MG132 was calculated using the impedance and image-based readouts presented in Examples II-IV. The area under the curve spanning from drug addition time to 60 hours post-addition was plotted as a function of MG132 concentration, resulting in the dose-response curves seen in Figure 16. The fit quality for the four different readouts was quite good, with R² values ​​ranging from 0.96 to 0.98. The calculated EC50 values ​​ranged from 0.86 μm to 3.0 μm, consistent with values ​​reported in the literature. Refer to Han, YH et al., The Effect of MG132, a Proteasome Inhibitor on HeLa Cells in Relation to Cell Growth, Reactive Oxygen Species and GSH. Oncol. Rep. 2009, 22(1), 215–21.

Claims

1. A system for monitoring biological samples electronically and optically, the system comprising: A multi-well plate having a plurality of wells configured to receive a plurality of biological samples, each well including a set of electrodes and a transparent window on the bottom surface of the well without electrodes; A lighting module configured to illuminate the hole; A bracket configured to receive the perforated plate, the bracket having an opening at its bottom configured to expose the transparent window of the perforation; An optical imaging module capable of moving across different holes in the same perforated plate to capture images through the exposed window; as well as A computer processor is configured to selectively operate each of a plurality of sets of electrodes for electronically monitoring the cell matrix impedance within one or more wells; the illumination module is configured to selectively illuminate the one or more wells. The optical imaging module is used for its selective movement and for capturing and receiving images from the one or more apertures. The computer processor is programmed to capture an image from the one or more apertures via the optical imaging module in response to the one or more apertures reaching or following an impedance-based value or impedance-based parameter set from electronic monitoring.

2. The system of claim 1, wherein the biological sample comprises cells, optionally including cancer cells.

3. The system of claim 1, wherein the lighting module comprises a plurality of lamps configured to independently illuminate one or more of the holes.

4. The system of claim 1, wherein the lighting module comprises an array of light-emitting diodes (LEDs), each LED being arranged to illuminate a single aperture.

5. The system according to claim 1, wherein the lighting module is a bright field lighting module.

6. The system of claim 1, wherein the bracket further comprises a hinged cover, wherein the lighting module is engaged with the cover.

7. The system of claim 1, wherein the bracket electrically engages the porous plate to communicate electronically with the plurality of electrodes and engages the lighting module to transmit lighting commands.

8. The system of claim 1, wherein the optical imaging module is configured to capture one or more images from a single aperture at a time.

9. The system of claim 1, wherein the optical imaging module is located below the bracket.

10. The system of claim 1, wherein the optical imaging system further comprises an excitation source configured to excite one or more molecules, the excitation source optionally comprising one or more light selected from ultraviolet, violet, blue, green, yellow, orange and red light.

11. The system of claim 1, wherein the optical imaging module includes a camera.

12. The system of claim 1, wherein the optical imaging module comprises a camera, a bandpass filter, a barrel lens, and an objective lens.

13. The system of claim 1, further comprising a computer processor, the computer processor being communicatively coupled to: The bracket is used to selectively operate each of the plurality of electrode sets for electronic monitoring of cell matrix impedance within one or more wells; The lighting module is used to selectively illuminate the one or more holes; And the optical imaging module, for its selective movement and Images are captured and received from the one or more holes.

14. The system of claim 13, wherein the computer processor is programmed to capture an image from the one or more apertures via the optical imaging module in response to the one or more apertures reaching or following a set impedance-based value or impedance-based parameter from the electronic monitoring.

15. The system of claim 13, wherein the processor is programmed to electronically monitor cell matrix impedance and optically monitor the same well, and is configured to pair the impedance and optical data for display or analysis.

16. The system of claim 1, further comprising: Two additional porous plates, each having multiple wells configured to receive multiple samples, each well including a set of electrodes and a transparent window without electrodes on the bottom surface of the well; Two additional lighting modules are configured to illuminate the holes in the two additional perforated plates; as well as Two additional brackets are configured to receive the two additional perforated plates, each of the two additional brackets having an open bottom that exposes the transparent window of the hole; The optical imaging module described therein is capable of moving across all the apertures to capture images through all the windows.

17. The system of claim 1, further comprising a cell or tissue culture container not configured for electronic monitoring, wherein the optical imaging module is configured to capture images within the cell or tissue culture container.

18. A system for monitoring biological samples electronically and optically, the system comprising: A multi-well plate having a plurality of wells configured to receive a plurality of biological samples, each well including a set of electrodes and a transparent window on the bottom surface of the well without electrodes; An optical imaging module configured to image the aperture; A lighting module configured to illuminate the hole; as well as A computer processor programmed to electronically monitor cellular matrix impedance and optically monitor the same well, and configured to couple impedance and optical data according to one or more of the following: i) Monitor cell matrix impedance electronically and capture images of the same well, and pair impedance and optical data for display or analysis; ii) Capturing an image from at least one aperture in response to one or more apertures reaching or following an impedance-based value or impedance-based parameter set from electronic monitoring; as well as iii) Electronly monitoring of cell matrix impedance between two consecutive electronic impedance monitoring sessions, within a time period including a certain time interval; and capturing images of the same well within the time period used for electronic monitoring or within a time period different from the electronic monitoring time period.

19. The system of claim 18, wherein the optical imaging module is capable of moving across different holes in the same porous plate to capture images through the exposed window; and in, The computer processor is communicatively coupled to the optical imaging module and the illumination module to: Selectively manipulate each of multiple sets of electrodes to electronically monitor the cell matrix impedance within one or more wells; Selectively illuminate one or more of the holes; as well as The optical imaging module is selectively operated to capture and receive images from the one or more apertures.

20. The system of claim 18, wherein the computer processor is programmed to capture an image from the one or more apertures via the optical imaging module in response to the one or more apertures reaching or following a set impedance-based value or impedance-based parameter from the electronic monitoring, and wherein the impedance-based value or impedance-based parameter indicates the establishment of a cell monolayer or a cell population.

21. The system of claim 18, wherein the lighting module comprises a plurality of lamps configured to independently illuminate one or more of the holes.

22. The system of claim 19, further comprising a bracket electrically engaging the perforated plate to electronically communicate with the plurality of electrodes and electrically engaging the lighting module to transmit lighting commands.

23. The system of claim 18, wherein the optical imaging module further comprises an excitation source configured to excite one or more molecules, the excitation source optionally comprising one or more light selected from ultraviolet, violet, blue, green, yellow, orange and red light.

Citation Information

Patent Citations

  • Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution

    US10012636B2

  • Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution

    US10533985B2

  • Real time electronic cell sensing systems and applications for cell-based assays

    US7192752B2

  • Impedance based devices and methods for use in assays

    US7470533B2

  • Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays

    US8344742B2